IDEAS home Printed from https://ideas.repec.org/a/nat/natcom/v6y2015i1d10.1038_ncomms7246.html
   My bibliography  Save this article

Off-target-free gene delivery by affinity-purified receptor-targeted viral vectors

Author

Listed:
  • Robert C. Münch

    (Molecular Biotechnology and Gene Therapy, Paul-Ehrlich-Institut)

  • Anke Muth

    (Molecular Biotechnology and Gene Therapy, Paul-Ehrlich-Institut)

  • Alexander Muik

    (Molecular Biotechnology and Gene Therapy, Paul-Ehrlich-Institut)

  • Thorsten Friedel

    (Molecular Biotechnology and Gene Therapy, Paul-Ehrlich-Institut)

  • Julia Schmatz

    (Center for Molecular Medicine Cologne (CMMC), University of Cologne
    German Center for Infection Research (DZIF), University of Cologne)

  • Birgit Dreier

    (University of Zurich)

  • Alexandra Trkola

    (Institute of Medical Virology, University of Zurich)

  • Andreas Plückthun

    (University of Zurich)

  • Hildegard Büning

    (Center for Molecular Medicine Cologne (CMMC), University of Cologne
    German Center for Infection Research (DZIF), University of Cologne)

  • Christian J. Buchholz

    (Molecular Biotechnology and Gene Therapy, Paul-Ehrlich-Institut
    German Cancer Consortium)

Abstract

We describe receptor-targeted adeno-associated viral (AAV) vectors that allow genetic modification of rare cell types ex vivo and in vivo while showing no detectable off-targeting. Displaying designed ankyrin repeat proteins (DARPins) on the viral capsid and carefully depleting DARPin-deficient particles, AAV vectors were made specific for Her2/neu, EpCAM or CD4. A single intravenous administration of vector targeted to the tumour antigen Her2/neu was sufficient to track 75% of all tumour sites and to extend survival longer than the cytostatic antibody Herceptin. CD4-targeted AAVs hit human CD4-positive cells present in spleen of a humanized mouse model, while CD8-positive cells as well as liver or other off-target organs remained unmodified. Mimicking conditions of circulating tumour cells, EpCAM-AAV detected single tumour cells in human blood opening the avenue for tumour stem cell tracking. Thus, the approach developed here delivers genes to target cell types of choice with antibody-like specificity.

Suggested Citation

  • Robert C. Münch & Anke Muth & Alexander Muik & Thorsten Friedel & Julia Schmatz & Birgit Dreier & Alexandra Trkola & Andreas Plückthun & Hildegard Büning & Christian J. Buchholz, 2015. "Off-target-free gene delivery by affinity-purified receptor-targeted viral vectors," Nature Communications, Nature, vol. 6(1), pages 1-9, May.
    • Handle: RePEc:nat:natcom:v:6:y:2015:i:1:d:10.1038_ncomms7246
    DOI: 10.1038/ncomms7246
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/ncomms7246
    File Function: Abstract
    Download Restriction: no
    File URL: https://libkey.io/10.1038/ncomms7246?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:6:y:2015:i:1:d:10.1038_ncomms7246. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.